Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT04824105

Modulating Anxious Coping

Led by Medical University of South Carolina · Updated on 2026-03-17

80

Participants Needed

1

Research Sites

287 weeks

Total Duration

On this page

Sponsors

M

Medical University of South Carolina

Lead Sponsor

N

National Institute of Mental Health (NIMH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a study to find out if a device that temporarily alters brain activity (repetitive transcranial magnetic stimulation, rTMS) might be used to change how people with anxiety or related concerns cope with feared or anxiety-producing situations. The study is recruiting people who recently started treatment for anxiety or a related concern. The study involves 3 visits to the Medical University of South Carolina. At the first visit, participants do interviews and surveys asking about anxiety and related concerns, and they also do tasks where they see and react to emotional pictures while their brain activation is measured. At the next two visits, participants receive rTMS, which works by rapidly turning a focused magnetic field on and off repeatedly over the head in a way that passes directly through the hair, scalp, and skull and onto the brain and can temporarily increase brain activity under the magnetic field. After rTMS, participants do two tasks where they see and react to emotional situations while wearing sensors on their hand, arms, face, and head. Each visit in this study is expected to last between 2 - 4 hours. This is not a treatment study, but the study is being conducted with the hope that it will help improve treatment in the future.

CONDITIONS

Official Title

Modulating Anxious Coping

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Ages 18 to 65 years
  • Diagnosed with an anxiety disorder, posttraumatic stress disorder, obsessive-compulsive disorder, or adjustment disorder with anxiety
  • Currently seeking mental health treatment
  • Able to read and provide informed consent
  • English is the first or primary language
Not Eligible

You will not qualify if you...

  • Current alcohol or substance use disorder more than mild severity
  • Lifetime diagnosis of psychotic disorder or bipolar mania
  • Neurological disorders that prevent TMS or neurophysiological recording (e.g., seizure disorder, traumatic brain injury with loss of consciousness, neurodegenerative diseases)
  • Medical conditions making it uncomfortable to sit or lie still for long periods
  • Standard contraindications for MRI or rTMS (metal in body, pregnancy, claustrophobia, sensitivity to noise, seizure history)
  • Currently taking anticholinergic, neuroleptic, or sedative/hypnotic medication (except stable SSRI or related drugs for at least 4 weeks)
  • Currently taking chronic opiate medications or substances
  • Currently taking naltrexone

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Medical University of South Carolina

Charleston, South Carolina, United States, 29425

Actively Recruiting

Loading map...

Research Team

C

Christopher T Sege, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here